LRVIYLABORATORIOS FARMACEUTICOS ROVI SA

About LABORATORIOS FARMACEUTICOS ROVI SA (LRVIY)

LABORATORIOS FARMACEUTICOS ROVI SA (LRVIY) is a N/A company headquartered in Madrid, Spain whose shares trade over-the-counter on the Pink tier.

Laboratorios Farmaceuticos Rovi, S.A. engages in the research, development, manufacture, and marketing of pharmaceutical products in Spain and internationally. The company provides products for cardiology, osteoarticular/women's health, anesthesia /pain, diagnostic imaging contrast agents, central nervous system, urology, endocrinology, respiratory, and primary healthcare areas. Its principal products include Ameride, Bertanel, Bluxam, Enoxaparin Rovi, Calcium Vitamine D3 Rovi, Exxiv, Prinvil, Rhodogil, Glufan, Hibor, Hirobriz Breezhaler, Neparvis, Medicebran, Medikinet, Mysimba, Orvatez, Tryptizol, Ulunar Breezhaler, and Volutsa; and hospital products, such as Iomeron and Iopamiro, Multihance and Y Prohance, Sonovue, Empowercta+, Empowermr, and CT Express, Fibrilin, and Sodium Heparin Rovi. It also provides contract-manufacturing services to other companies for a range of pharmaceutical forms, including prefilled syringes, vials, suppositories, tablets, and sachets.

LRVIY key facts

Ticker symbol

LRVIY

Market tier

Pink

Headquarters

Madrid, Spain

Country of incorporation

ES

Shares outstanding

53,192,000

Reporting standard

International Reporting: Madrid Stock Exchange

Audit status

Audited

Fiscal year end

12/31

Explore more: Pink stocks · OTC stocks starting with L